E-

Esbe - Pharma

BE0430.045.342

Gross margin
€ 188K ↑ 10% 2025 Total € 1.78M
Profit
€ 114K ↑ 12% 2025 Total € 983K
EBITDA
€ 185K ↑ 11% 2025 Total € 1.73M
EBIT
€ 175K ↑ 11% 2025 Total € 1.59M
Net profit
€ 114K ↑ 12% 2025 Total € 983K
Capex
€ 4K ↑ 354% 2025 Total € 142K
Assets
€ 808K ↑ 16% 2025
Equity
€ 740K ↑ 18% 2025
Debt
€ 68K ↓ 6% 2025
Cash
€ 651K ↑ 20% 2025
Cashflow
€ 124K ↑ 12% 2025 Total € 1.12M
Working capital
€ 727K ↑ 20% 2025
Current ratio
11.63 ↑ 24% 2025
Quick ratio
10.14 ↑ 25% 2025
Working capital ratio
11.63 ↑ 24% 2025
Debt
€ 68K ↓ 6% 2025
Short-term debt
€ 68K ↓ 6% 2025
Debt / EBITDA
0.37 ↓ 14% 2025
Solvability
91.5% ↑ 1.9 pt 2025
Gross profitability
16.7% ↓ 1 pt 2025
Net profitability
15.4% ↓ 0.8 pt 2025
Return On Assets (ROA)
14.10 ↓ 3% 2025
Return On Equity (ROE)
15.40 ↓ 5% 2025
Customer credit
15.05 2006
Days Sales Outstanding (DSO)
15.05 2006
Taxes
€ 37K ↑ 49% 2025 Total € 223K
Dividends
€ 14K ↓ 96% 2016 Total € 611K
Dividend payout
25.0% ↓ 846.4 pt 2016